Labiana Health S.A. Market Cap ($45.42 Million)
Market Cap & Net Worth: Labiana Health S.A. (LAB)
Labiana Health S.A. market cap. Labiana Health S.A. (MC:LAB) has a market capitalization of $45.42 Million (€38.85 Million) as of November 1, 2026. Listed on the MC stock exchange, this Spain-based company holds position #22093 globally and #163 in its home market, demonstrating a 4.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Labiana Health S.A.'s stock price €5.20 by its total outstanding shares 8489255 (8.49 Million). Also see Labiana Health S.A. cash flow conversion for how efficiently the company converts equity into cash flow.
Labiana Health S.A. Market Cap History (2022–2026)
Labiana Health S.A. market cap history from 2022 to 2026. Data shows growth from $33.35 Million to $51.61 Million (2.86% CAGR). Check LAB live share price for real-time trading data and today's change.
Labiana Health S.A. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Labiana Health S.A.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore how fast is Labiana Health S.A. growing its equity to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.64x
Labiana Health S.A.'s market cap is 0.64 times its annual revenue
Latest Price to Earnings (P/E) Ratio
18.70x
Labiana Health S.A.'s market cap is 18.70 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $33.35 Million | $57.85 Million | -$8.94 Million | 0.58x | N/A |
| 2023 | $12.41 Million | $58.46 Million | -$4.42 Million | 0.21x | N/A |
| 2024 | $29.38 Million | $66.26 Million | $253.45K | 0.44x | 115.91x |
| 2025 | $48.04 Million | $75.18 Million | $2.57 Million | 0.64x | 18.70x |
Competitor Companies of LAB by Market Capitalization
Companies near Labiana Health S.A. in the global market cap rankings as of November 1, 2026. Also see LAB total asset value for a full breakdown of the balance sheet.
Key companies related to Labiana Health S.A. by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #535 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #593 globally with a market cap of $45.23 Billion USD ( CN¥309.13 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #511 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #535 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.62 |
| #593 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.23 Billion | CN¥48.46 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.30 |
Market Capitalization of Labiana Health S.A. (2022–2026)
Market capitalization of Labiana Health S.A. from 2022 to today. Between 2022 and today, Labiana Health S.A.'s market cap moved from $33.35 Million to $ 51.61 Million, with a yearly change of 2.86%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €51.61 Million | +7.44% |
| 2025 | €48.04 Million | +63.51% |
| 2024 | €29.38 Million | +136.80% |
| 2023 | €12.41 Million | -62.80% |
| 2022 | €33.35 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Labiana Health S.A. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $45.42 Million USD |
| MoneyControl | $45.42 Million USD |
| MarketWatch | $45.42 Million USD |
| marketcap.company | $45.42 Million USD |
| Reuters | $45.42 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Labiana Health S.A.
Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, rest of European Union, North America, and internationally. It offers anesthetics-sedatives, anti-infectives, anti-inflammatories, antiparasitics, hormonals, nutritional products, metabolism regulators, and vitamin products. The company also provides sterile and lyophilized dosage f… Read more